SCHRODER INVESTMENT MANAGEMENT GROUP - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 124 filers reported holding INSYS THERAPEUTICS INC NEW in Q2 2016. The put-call ratio across all filers is 5.78 and the average weighting 0.1%.

Quarter-by-quarter ownership
SCHRODER INVESTMENT MANAGEMENT GROUP ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2017$1,690,000
+225.6%
153,788
+172.4%
0.00%
+100.0%
Q4 2016$519,000
-29.1%
56,455
-9.1%
0.00%0.0%
Q3 2016$732,000
-22.2%
62,122
-14.5%
0.00%
-50.0%
Q2 2016$941,000
-23.6%
72,697
-6.2%
0.00%
-33.3%
Q1 2016$1,231,00077,4990.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q2 2016
NameSharesValueWeighting ↓
Raging Capital Management, LLC 295,790$1,367,0000.20%
Jump Trading, LLC 42,400$196,0000.06%
GAM Holding AG 83,940$388,0000.02%
Magnus Financial Group LLC 13,393$62,0000.01%
PANAGORA ASSET MANAGEMENT INC 438,606$2,026,0000.01%
Quantamental Technologies LLC 3,898$18,0000.01%
QS Investors, LLC 155,683$719,0000.01%
SFMG, LLC 11,994$55,0000.01%
Winslow, Evans & Crocker, Inc. 4,060$20,0000.01%
MILLENNIUM MANAGEMENT LLC 812,262$3,753,0000.01%
View complete list of INSYS THERAPEUTICS INC NEW shareholders